Concepedia
Statistics
Publications
23
Citations
1.6K
H-Index
18
Active since
1999
Affiliations
Yale University(Current)
University of Saint Joseph
Yale Cancer Center
Wesleyan University
VA Connecticut Healthcare System
Christopher R. Zito is an author at Yale University specializing in medicine, oncology, and pharmacology.
Publications per year
1999–2024
Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial
Harriet M. Kluger, Veronica Chiang, Amit Mahajan et al. · Journal of Clinical Oncology · 2018 · 277 citations
Medicine, Oncology, Immunotherapy +16
Characterization of PD-L1 Expression and Associated T-cell Infiltrates in Metastatic Melanoma Samples from Variable Anatomic Sites
Harriet M. Kluger, Christopher R. Zito, Meaghan L. Barr et al. · Clinical Cancer Research · 2015 · 203 citations · Full text
Medicine, Cancer Biology, Immunology +17
PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors
Harriet M. Kluger, Christopher R. Zito, Gabriela Turcu et al. · Clinical Cancer Research · 2017 · 156 citations · Full text
Medicine, Immunology, Oncology +17
PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases
Lucia B. Jilaveanu, Brian Shuch, Christopher R. Zito et al. · Journal of Cancer · 2014 · 155 citations · Full text
Medicine, Oncology, Pathology +17
Dimeric SecA is essential for protein translocation
Lucia B. Jilaveanu, Christopher R. Zito, Donald Oliver · Proceedings of the National Academy of Sciences · 2005 · 102 citations
Life Sciences, Biochemistry, Molecular Biology +17
1–5 of 23